C-Abl inhibition; a novel therapeutic target for Parkinson’s disease

• Main Authors: Abushouk, Abdelrahman Ibrahim, Negida, Ahmed, Abdelsalam Elshenawy, Rasha A, Zein, Hossam, Hammad, Ali M, Menshawy, Ahmed, Mohamed, Wael Mohamed Yousef
• Format: Article
• Language: English; English; English
• Published: Bentham Science Publishers B.V. 2018
• Subjects: R Medicine (General)
• Online Access: http://irep.iium.edu.my/58689/1/58689_C-Abl%20inhibition.pdf; http://irep.iium.edu.my/58689/2/58689_C-Abl%20inhibition_SCOPUS.pdf; http://irep.iium.edu.my/58689/3/58689_C-Abl%20inhibition_WOS.pdf; http://irep.iium.edu.my/58689/; http://www.eurekaselect.com/152890/article

Parkinson’s disease (PD) is the most prevalent movement disorder in the world. The major pathological hallmarks of PD are death of dopaminergic neurons and the formation of Lewy bodies. At the moment, there is no cure for PD; current treatments are symptomatic. Investigators are searching for neu...